An Independent US FDA: Gottlieb Supports Position, But Is Pessimistic About Prospects
In an interview with the Pink Sheet, Scott Gottlieb agrees with other ex-commissioners that there are benefits to an independent agency, but he thinks political forces would prevent it from ever happening.
You may also be interested in...
Former agency heads and outside experts suggest structural reforms in interviews with GAO. Report notes FDA had 10 political appointees in 2020 versus 5 in 2016 and 3 in 2022. House Select Subcommittee on the Coronavirus Crisis describes Trump Administration actions against FDA in its final report.
Three of the US FDA’s former leaders believe the agency is coming through COVID with its reputation intact. They still support making the agency independent of the broader Health & Human Services Department, but the urgency may be gone.
The political spotlight on the FDA during the coronavirus pandemic has renewed a long-standing debate as to whether it should be made an independent, Cabinet-level federal agency and freed from direct HHS oversight.